Sun Pharmaceutical Industries company profile

SUNPHARMA · NSE · INR

Compare Sun Pharmaceutical Industries
₹1,880.00Change from previous close: −0.27%Absolute change: −₹5.00

Close · November 13, 2026

Company profile

Sun Pharmaceutical Industries has 47,000 employees and is headquartered in Mumbai, India.

Its tablets, capsules, injectables, inhalers and creams reach patients through a portfolio spanning neuropsychiatry, cardiology, diabetes, gastroenterology and oncology, among other areas. Alongside prescription medicines, the group sells over-the-counter vitamins, analgesics and digestive products, as well as antiretroviral drugs, peptides and steroids. It also supplies active pharmaceutical ingredients and generics for anti-cancer, immunosuppressant and controlled-substance medicines, with operations in India, the United States and other international markets.

In the fiscal year ended March 2026, Sun Pharmaceutical Industries Limited reported revenue of 584.6 billion rupees, up 11.2% from the previous year, and a net profit of 114.8 billion rupees. The company employs 47,000 people. Its headquarters are in Mumbai, India, and the company dates from 1983.

Company facts

Industry
Drug Manufacturers - Specialty & Generic
Country
India
Headquarters
Sun House, 400063, Mumbai
Employees
47,000
Chief executive
Kirti Ganorkar
Founded
1983
Fiscal year
April - March
Listing
SUNPHARMA · NSE
Currency
INR
ISIN
INE044A01036

Sun Pharmaceutical Industries and its competitors

The most similar companies by business and size

CompanyCountryMarket capEmployeesOperating marginP/E (trailing 12 months)
Sun Pharmaceutical IndustriesSUNPHARMAIndia$47.94B47,00023.3%40.9
Jiangsu Hengrui Pharmaceuticals600276China$47.86B20,60227.4%35.9
Takeda Pharmaceutical4502Japan$65.79B47,02916.6%253.2
Divi's LaboratoriesDIVISLABIndia$31.67B11,56534.0%88.0
Hansoh Pharmaceutical Group3692Hong Kong SAR China$25.82B9,64337.3%27.6
Torrent PharmaceuticalsTORNTPHARMIndia$19B18,25822.2%78.9

Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.

Compare Sun Pharmaceutical Industries with its competitors